These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24738805)

  • 1. Cardiac biomarkers in the prediction of risk in the non-cardiac surgery setting.
    Biccard BM; Devereaux PJ; Rodseth RN
    Anaesthesia; 2014 May; 69(5):484-93. PubMed ID: 24738805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the best pre-operative risk stratification tool for major adverse cardiac events following elective vascular surgery? A prospective observational cohort study evaluating pre-operative myocardial ischaemia monitoring and biomarker analysis.
    Biccard BM; Naidoo P; de Vasconcellos K
    Anaesthesia; 2012 Apr; 67(4):389-95. PubMed ID: 22324824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality.
    Provenchère S; Berroeta C; Reynaud C; Baron G; Poirier I; Desmonts JM; Iung B; Dehoux M; Philip I; Bénessiano J
    Crit Care Med; 2006 Apr; 34(4):995-1000. PubMed ID: 16484891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B type natriuretic peptide--a diagnostic breakthrough in peri-operative cardiac risk assessment?
    Rodseth RN
    Anaesthesia; 2009 Feb; 64(2):165-78. PubMed ID: 19143695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery.
    Chong CP; Lim WK; Velkoska E; van Gaal WJ; Ryan JE; Savige J; Burrell LM
    Am J Cardiol; 2012 May; 109(9):1365-73. PubMed ID: 22381157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cardiac biomarkers in neonatology.
    Vijlbrief DC; Benders MJ; Kemperman H; van Bel F; de Vries WB
    Pediatr Res; 2012 Oct; 72(4):337-43. PubMed ID: 22797141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of brain natriuretic peptide in prognostication and reclassification of risk in patients undergoing vascular surgery.
    Biccard BM; Naidoo P
    Anaesthesia; 2011 May; 66(5):379-85. PubMed ID: 21480839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does preoperative B-type natriuretic peptide better predict adverse outcome and prolonged length of stay than the standard European System for Cardiac Operative Risk Evaluation after cardiac surgery?
    Fellahi JL; Daccache G; Rubes D; Massetti M; Gérard JL; Hanouz JL
    J Cardiothorac Vasc Anesth; 2011 Apr; 25(2):256-62. PubMed ID: 20674395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor 15: a novel risk marker adjunct to the EuroSCORE for risk stratification in cardiac surgery patients.
    Heringlake M; Charitos EI; Gatz N; Käbler JH; Beilharz A; Holz D; Schön J; Paarmann H; Petersen M; Hanke T
    J Am Coll Cardiol; 2013 Feb; 61(6):672-81. PubMed ID: 23391200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
    Feringa HH; Bax JJ; Elhendy A; de Jonge R; Lindemans J; Schouten O; van den Meiracker AH; Boersma E; Schinkel AF; Kertai MD; van Sambeek MR; Poldermans D
    Am J Cardiol; 2006 Jul; 98(1):111-5. PubMed ID: 16784932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery.
    Chong CP; Ryan JE; van Gaal WJ; Lam QT; Sinnappu RN; Burrell LM; Savige J; Lim WK
    Am J Cardiol; 2010 Sep; 106(6):865-72. PubMed ID: 20816130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediately postoperative B-type natriuretic peptide and its predictive value.
    Suttie S; Mofidi R; McCallum R; Christie S; Flett M; Nagy J; Griffiths G; McLeod S; Struthers A; Stonebridge P
    Ann Vasc Surg; 2011 Feb; 25(2):248-55. PubMed ID: 21131173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous measurement of cardiac troponin I, B-type natriuretic peptide, and C-reactive protein for the prediction of long-term cardiac outcome after cardiac surgery.
    Fellahi JL; Hanouz JL; Le Manach Y; Gué X; Monier E; Guillou L; Riou B
    Anesthesiology; 2009 Aug; 111(2):250-7. PubMed ID: 19568166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery.
    Hutfless R; Kazanegra R; Madani M; Bhalla MA; Tulua-Tata A; Chen A; Clopton P; James C; Chiu A; Maisel AS
    J Am Coll Cardiol; 2004 May; 43(10):1873-9. PubMed ID: 15145114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery.
    Bolliger D; Seeberger MD; Lurati Buse GA; Christen P; Rupinski B; Gürke L; Filipovic M
    Anesth Analg; 2009 Apr; 108(4):1069-75. PubMed ID: 19299763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is brain natriuretic peptide a marker for adverse postoperative outcomes in patients undergoing cardiac surgery?
    Mitchell J; Webb ST
    Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):467-72. PubMed ID: 21186284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum cardiac specific biomarker release after non-cardiac thoracic surgery.
    Muley T; Kurz M; Männle C; Alekozai A; Winteroll S; Dienemann H; Schmidt W; Pfannschmidt J
    Clin Lab; 2011; 57(11-12):925-32. PubMed ID: 22239023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 12-month outcome after cardiac surgery: prediction by troponin T in combination with the European system for cardiac operative risk evaluation.
    Lurati Buse GA; Koller MT; Grapow M; Brüni CM; Kasper J; Seeberger MD; Filipovic M
    Ann Thorac Surg; 2009 Dec; 88(6):1806-12. PubMed ID: 19932239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.